EFFECTS OF ACLACINOMYCIN-A ON MURINE LEUKEMIANARA N; MIYAMOTO T; HIRASHIMA K et al.1982; BLOOD; ISSN 0006-4971; USA; DA. 1982; VOL. 60; NO 1; PP. 188-193; BIBL. 16 REF.Article

ADRIAMYCIN-ACTIVATED MACROPHAGES AS TUMOR GROWTH INHIBITORSHASKILL JS.1981; CANCER RES.; ISSN 0008-5472; USA; DA. 1981; VOL. 41; NO 10; PP. 3852-3856; BIBL. 16 REF.Article

A PHASE I AND CLINICAL PHARMACOLOGY STUDY OF INTRAVENOUSLY ADMINISTERED CARMINOMYCIN IN CANCER PATIENTS IN THE UNITED STATESCOMIS RL; ISSELL BF; PITTMAN K et al.1982; CANCER RES.; ISSN 0008-5472; USA; DA. 1982; VOL. 42; NO 7; PP. 2944-2948; BIBL. 15 REF.Article

ADRIAMYCIN STIMULATES ONLY THE IRON ION-INDUCED, NADPH-DEPENDENT MICROSOMAL ALKANE FORMATIONMULIAWAN H; SCHEULEN ME; KAPPUS H et al.1982; BIOCHEMICAL PHARMACOLOGY; ISSN 0006-2952; GBR; DA. 1982; VOL. 31; NO 19; PP. 3147-3150; BIBL. 16 REF.Article

SELF-ASSOCIATION OF DAUNOMYCINCHAIRES JB; DATTAGUPTA N; CROTHERS DM et al.1982; BIOCHEMISTRY (EASTON); ISSN 0006-2960; USA; DA. 1982; VOL. 21; NO 17; PP. 3927-3932; BIBL. 18 REF.Article

ELECTROCHEMICAL REDUCTION PATHWAYS OF ANTHRACYCLINE ANTIBIOTICSBERG H; HORN G; IHN W et al.1982; JOURNAL OF ANTIBIOTICS; ISSN 0021-8820; JPN; DA. 1982; VOL. 35; NO 7; PP. 800-805; BIBL. 14 REF.Article

ANTITUMOR ANTIBIOTICS. I: ANTHRACYCLINESMYERS CE.1982; CANCER CHEMOTHERAPY; ISSN 505242; NLD; DA. 1982; NO 4; PP. 51-68; BIBL. 78 REF.Article

MECHANISM OF ADRIAMYCIN CARDIOTOXICITY: EVIDENCE FOR OXIDATIVE STRESSOLSON RD; BOERTH RC; GERBER JG et al.1981; LIFE SCI. (1973); ISSN 0024-3205; GBR; DA. 1981; VOL. 29; NO 14; PP. 1393-1401; BIBL. 44 REF.Article

BREVET. ANTHRACYCLINE ANTIBIOTICS AND THEIR PREPARATION METHOD = LES ANTIBIOTIQUES DE LA FAMILLE DES ANTHRACYCLINES ET LEUR METHODE DE PREPARATION1983; ; EUR; DA. 1983-03-02; EP/A1/0 072 974; DEP.82107295.6/1982-08-11; PR. JP/107256-82/1982-06-21; 40 P.Patent

LOCAL AND SYSTEMIC TOXICITY RESULTING FROM LARGE-VOLUME IP ADMINISTRATION OF DOXORUBICIN IN THE RATLITTERST CL; COLLINS JM; LOWE MC et al.1982; CANCER TREAT. REP.; ISSN 0361-5960; USA; DA. 1982; VOL. 66; NO 1; PP. 157-161; BIBL. 16 REF.Article

CHEMICAL MODIFICATION OF ANTHRACYCLINE ANTIBIOTICS. III: 4'''-AMINO, 4'''-ALKYLAMINO AND 4'''-AMIDE DERIVATIVES OF ACLACINOMYCIN ATANAKA H; YOSHIOKA T; SHIMAUCHI Y et al.1981; J. ANTIBIOT.; ISSN 0021-8820; JPN; DA. 1981; VOL. 34; NO 7; PP. 850-855; BIBL. 7 REF.Article

Total synthesis of 11-deoxyanthracyclines: 4-demethoxy-11-deoxy-daunomycin, 11-deoxydaunomycin, and their analoguesTAMURA, Y; AKAI, S; KISHIMOTO, H et al.Chemical and pharmaceutical bulletin. 1988, Vol 36, Num 10, pp 3897-3914, issn 0009-2363Article

14-Fluoroanthracyclines. Novel syntheses and antitumor activityMATSUMOTO, T; OHSAKI, M; YAMADA, K et al.Chemical and pharmaceutical bulletin. 1988, Vol 36, Num 10, pp 3793-3804, issn 0009-2363Article

Re-searching anthracycline therapyOAKMAN, Catherine; MORETTI, Erica; DI LEO, Angelo et al.Breast cancer research and treatment. 2010, Vol 123, Num 1, pp 171-175, issn 0167-6806, 5 p.Article

Adriamycin and other anthracyclinesEHRKE, M. J; MIHICH, E.Clinics in immunology and allergy. 1984, Vol 4, Num 2, pp 259-277, issn 0260-4639Article

Thin-layer chromatographic separation of new semisynthetic derivatives of daunomycinoneJIZBA, J. V; PRIKRYLOVA, V; LIPAVSKA, H et al.Journal of chromatography. 1983, Vol 257, Num 1, pp 185-187, issn 0021-9673Article

Prévention de la cardiotoxicité des anthracyclines : approche fondamentale des mécanismes mis en jeu ; relations avec les données cliniques = Preventing the cardiotoxic effects of anthracyclins. from basic concepts to clinical dataDELEMASURE, S; VERGELY, C; ZELLER, M et al.Annales de cardiologie et d'angéiologie (Paris). 2006, Vol 55, Num 2, pp 104-112, issn 0003-3928, 9 p.Article

Redox-cycling of anthracyclines by thioredoxin system : Increased superoxide generation and DNA damageRAVI, Dashnamoorthy; DAS, Kumuda C.Cancer chemotherapy and pharmacology. 2004, Vol 54, Num 5, pp 449-458, issn 0344-5704, 10 p.Article

PIGMENTATION UNGUEALE AU COURS DE TRAITEMENTS PAR CYCLOPHOSPHAMIDE ET DOXORUBICINE = FINGERNAIL PIGMENTATION IN PATIENTS UNDER CYCLOPHOSPHAMIDE AND DOXORUBICINEMANIGAND G; FAUX N; DUMAS D et al.1983; SEMAINE DES HOPITAUX; ISSN 0037-1777; FRA; DA. 1983; VOL. 59; NO 24; PP. 1840-1841; ABS. ENG/FRE; BIBL. 16 REF.Article

INTERACTION OF ADRIAMYCIN WITH DNA AS STUDIED BY RESONANCE RAMAN SPECTROSCOPYMANFAIT M; ALIX AJP; JEANNESSON P et al.1982; NUCLEIC ACIDS RES.; ISSN 0305-1048; GBR; DA. 1982; VOL. 10; NO 12; PP. 3803-3816; BIBL. 25 REF.Article

ISOTACHOPHORETIC DETERMINATION OF ADRIAMYCIN AND ADRIAMYCINOL IN HUMAN PLASMAAKEDO H; SHINKAI K.1982; J. CHROMATOGR.; ISSN 0021-9673; NLD; DA. 1982; VOL. 227; NO 1; PP. 262-265; BIBL. 10 REF.Article

ELUCIDATION DE STRUCTURE ET COMPORTEMENT DE PRODUITS NATURELS SOUS IONISATION CHIMIQUE. I: MISE EN EVIDENCE DE LA CINERUBINE A PAR ETUDE DES DECOMPOSITIONS UNIMOLECULAIRES DES IONS PRODUITS EN PHASE GAZEUSE PAR ^IBU⁺DAVID L; SCANZI E; FRAISSE D et al.1982; TETRAHEDRON; ISSN 0040-4020; GBR; DA. 1982; VOL. 38; NO 11; PP. 1619-1629; ABS. ENG; BIBL. 18 REF.Article

ADRIAMYCIN CARDIOTOXICITY, PROGNOSTIC VALUE OF THE SYSTOLIC TIME INTERVALSCHAUDRON JM; BEAUDUIN M; DELWICHE JP et al.1982; ACTA CARDIOL.; ISSN 0001-5385; BEL; DA. 1982; VOL. 37; NO 2; PP. 105-115; BIBL. 3 P.Article

BREVET. PROCESS FOR ACLACINOMYCINS AND MICROORGANISM USED THEREIN1982; ; EUR; DA. 1982-05-05; EP/A1/0 050 725; DEP.81106922-8/1981-09-04; PR. GB/8034537/1980-10-27; 20 P.Patent

Pathogenesis of cardiotoxicity induced by anthracyclinesELLIOTT, Perry.Seminars in oncology. 2006, Vol 33, Num 3, issn 0093-7754, S2-S7, SUP8Conference Paper